The Efficacy of Combination of Traditional Tibetan and Remote Ischemic Conditioning on High Altitude Polycythemia
Phase 2
Not yet recruiting
- Conditions
- High Altitude Polycythemia
- Interventions
- Drug: Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill)Device: Remote Ischemic Conditioning
- Registration Number
- NCT06082583
- Lead Sponsor
- Capital Medical University
- Brief Summary
A multicenter, randomized controlled trial was designed to evaluate the effectiveness and safety of the comprehensive traditional Tibetan medicine program combined with remote ischemic conditioning on high altitude polycythemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Patients with high-altitude polycythemia aging 18 to 65 years.
Exclusion Criteria
- Allergic to Tibetan medicine ingredients;
- Inappropriate to receive Tibetan medicine treatment and/or remote ischemic conditioning.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tibetan Medicine Group Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill) - Tibetan Medicine-Remote Ischemic Conditioning Group Remote Ischemic Conditioning - Tibetan Medicine-Remote Ischemic Conditioning Group Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill) -
- Primary Outcome Measures
Name Time Method The incidence of effective treatment Baseline and 1 month after treatment. The hemoglobin levels decreased ≥20% after treatment compared to pre-treatment.
- Secondary Outcome Measures
Name Time Method